참고문헌
- Talapko J, Juzbasic M, Matijevic T, Pustijanac E, Bekic S, Kotris I, et al. 2021. Candida albicans-the virulence factors and clinical manifestations of infection. J. Fungi 7: 79.
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317. https://doi.org/10.1086/421946
- Idelevich EA, Grunewald CM, Wullenweber J, Becker K. 2014. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS One 9: e114834.
- Buder S and Lautenschlager S. 2020. Gonorrhea and urethritis, pp. 1-8. In Landthaler M, Plewig G, Burgdorf WHC, WolffPlewig H (eds.), Braun-Falco's Dermatology. Springer Germany, Berlin.
- Bukhary Z. 2008. Candiduria: a review of clinical significance and management. Saudi J. Kidney Dis. Transpl. 19: 350-360.
- Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis. 29: 1164-1170. https://doi.org/10.1086/313450
- Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. 1988. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148: 2642-2645. https://doi.org/10.1001/archinte.1988.00380120094019
- Kim GY, Jeon JS, Kim JK. 2016. Isolation frequency characteristics of Candida species from clinical specimens. Mycobiology 44: 99-104. https://doi.org/10.5941/MYCO.2016.44.2.99
- Zeng X, Zhang Y, Zhang T, Xue Y, Xu H, An R. 2018. Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi'an: A cross-sectional study. Biomed. Res. Int. 2018: 9703754.
- Holland J, Young ML, Lee O, C-A Chen, S. 2003. Vulvovaginal carriage of yeasts other than Candida albicans. Sex. Transm. Infect. 79: 249-250. https://doi.org/10.1136/sti.79.3.249
- Gottfredsson M, Cox GM, Perfect JR. 1998. Molecular methods for epidemiological and diagnostic studies of fungal infections. Pathology 30: 405-418. https://doi.org/10.1080/00313029800169726
- Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, et al. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44: 399-408. https://doi.org/10.1099/00222615-44-6-399
- Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soll DR. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35: 2348-2358. https://doi.org/10.1128/jcm.35.9.2348-2358.1997
- Shin JH, Kook H, Shin DH, Hwang TJ, Kim M, Suh SP, et al. 2000. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis. 19: 344-349. https://doi.org/10.1007/s100960050491
- Alhussaini MS, El-Tahtawi NF, Moharram AM. 2013. Phenotypic and molecular characterization of Candida species in urine samples from renal failure patients. Sci. J. Clin. Med. 2: 14-25. https://doi.org/10.11648/j.sjcm.20130201.13
- Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin. Infect. Dis. 30: 14-18. https://doi.org/10.1086/313583
- Lal S, Parkash O, Kumar P, Malik ZA. 2021. Determination of predisposing factors in developing Candida albicans associated urinary tract infection and antifungal sensitivity profile. J. Pharm. Res Int. 33: 40-49. https://doi.org/10.9734/jpri/2021/v33i631188
- Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A. 2011. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J. Pathol. Microbiol. 54: 552-555. https://doi.org/10.4103/0377-4929.85091
- Mohammed TK, Wahab KM, Jawad MA. 2019. Isolation and identification of Candida albicans in different clinical samples. AlNisour J. Med. Sci. 1: 85-97. https://doi.org/10.70492/2664-0554.1024
- Marak MB, Dhanashree B. 2018. Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples. Int. J. Microbiol. 2018: 7495218.
- Ghasemi R, Rabiei MM, Lotfali E, Abolghasemi, S, Ansari S. 2020. Candiduria: prevalence, identification of isolated Candida species and trends in antifungal susceptibility in hospitalized patients. Nov. Biomed. 8: 71-76.
- Jeon JS, Kim JK. 2019. Analysis of the distribution and antifungal susceptibility of Candida albicans and non-albicans Candida isolated from human blood culture. AMJ 12: 90-97. https://doi.org/10.21767/AMJ.2018.3572
- Espinosa-Hernandez VM, Morales-Pineda V, Martinez-Herrera E. 2020. Skin infections caused by emerging Candida species. Curr. Fung. Infect. Rep. 14: 99-105. https://doi.org/10.1007/s12281-020-00380-9
- Avcioglu F, Sirmatel F, Behcet M, Ozarslan TO, Gozdas HT. 2021. Investigation of a healthcare-associated candida infections in a Turkish intensive care unit: risk factors, therapy and clinical outcome. Exp. Biomed. Res. 4: 9-15. https://doi.org/10.30714/j-ebr.2021165773